NMC
PGEN icon

Nine Masts Capital’s Precigen PGEN Stock Holding History

Nine Masts Capital’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,608
Closed -$44.9K – 265
2026
Q1 		$44.9K Buy
+11,608
New +$47.6K 0.01% 156

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nine Masts Capital's PGEN Position: Q2 2026 in Review

Nine Masts Capital sold out of Precigen (PGEN) in Q2 2026, closing a stake of 11,608 shares — an estimated $44.9K sold.

Nine Masts Capital first reported a position in PGEN in Q1 2026 and held it in 1 quarter. The position peaked at $44.9K in Q1 2026. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Nine Masts Capital reported no remaining Precigen position as of Q2 2026 after selling out during the quarter.
  • Nine Masts Capital sold 11,608 Precigen shares in Q2 2026, an estimated $44.9K.
  • Nine Masts Capital first reported a position in Precigen in Q1 2026 and held it in 1 quarter.
  • Nine Masts Capital's Precigen position peaked at $44.9K in Q1 2026.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Nine Masts Capital's 13F filing for Q2 2026, filed 7 Aug 2026.